Cancer biomarkers [[electronic resource] ] : analytical techniques for discovery / / Mahmoud H. Hamdan |
Autore | Hamdan Mahmoud <1947-> |
Pubbl/distr/stampa | Hoboken, N.J., : Wiley-Interscience, c2007 |
Descrizione fisica | 1 online resource (405 p.) |
Disciplina | 616.994075 |
Collana | Wiley-Interscience series on mass spectrometry |
Soggetto topico | Tumor markers |
Soggetto genere / forma | Electronic books. |
ISBN |
1-280-82219-8
9786610822195 0-470-11312-X 0-470-11311-1 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Overview -- Proteomic platforms for biomarkers discovery -- Some existing cancer biomarkers -- Potential cancer biomarkers -- Protein networks and protein phosphorylation in cancer -- Ethical issues and initiatives relevant to cancer biomarkers. |
Record Nr. | UNINA-9910143419303321 |
Hamdan Mahmoud <1947-> | ||
Hoboken, N.J., : Wiley-Interscience, c2007 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Cancer biomarkers [[electronic resource] ] : analytical techniques for discovery / / Mahmoud H. Hamdan |
Autore | Hamdan Mahmoud <1947-> |
Pubbl/distr/stampa | Hoboken, N.J., : Wiley-Interscience, c2007 |
Descrizione fisica | 1 online resource (405 p.) |
Disciplina | 616.994075 |
Collana | Wiley-Interscience series on mass spectrometry |
Soggetto topico | Tumor markers |
ISBN |
1-280-82219-8
9786610822195 0-470-11312-X 0-470-11311-1 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Overview -- Proteomic platforms for biomarkers discovery -- Some existing cancer biomarkers -- Potential cancer biomarkers -- Protein networks and protein phosphorylation in cancer -- Ethical issues and initiatives relevant to cancer biomarkers. |
Record Nr. | UNINA-9910829908303321 |
Hamdan Mahmoud <1947-> | ||
Hoboken, N.J., : Wiley-Interscience, c2007 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Cancer biomarkers : analytical techniques for discovery / / Mahmoud H. Hamdan |
Autore | Hamdan Mahmoud <1947-> |
Pubbl/distr/stampa | Hoboken, N.J., : Wiley-Interscience, c2007 |
Descrizione fisica | 1 online resource (405 p.) |
Disciplina | 616.99/4075 |
Collana | Wiley-Interscience series on mass spectrometry |
Soggetto topico | Tumor markers |
ISBN |
1-280-82219-8
9786610822195 0-470-11312-X 0-470-11311-1 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Overview -- Proteomic platforms for biomarkers discovery -- Some existing cancer biomarkers -- Potential cancer biomarkers -- Protein networks and protein phosphorylation in cancer -- Ethical issues and initiatives relevant to cancer biomarkers. |
Record Nr. | UNINA-9910876899303321 |
Hamdan Mahmoud <1947-> | ||
Hoboken, N.J., : Wiley-Interscience, c2007 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Proteomics today [[electronic resource] ] : protein assessment and biomarkers using mass spectrometry, 2D electrophoresis, and microarray technology / / Mahmoud Hamdan, Pier Giorgio Righetti |
Autore | Hamdan Mahmoud <1947-> |
Pubbl/distr/stampa | Hoboken, N.J., : John Wiley & Sons, 2005 |
Descrizione fisica | 1 online resource (446 p.) |
Disciplina |
572.6
572.636 |
Altri autori (Persone) | RighettiP. G |
Collana | Wiley-Interscience series in mass spectrometry |
Soggetto topico |
Proteins - Spectra
Mass spectrometry Proteomics |
Soggetto genere / forma | Electronic books. |
ISBN |
1-280-27548-0
9786610275489 0-470-24684-7 0-471-70910-7 0-471-70915-8 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
PROTEOMICS TODAY; CONTENTS; PREFACE TO PART I; ACKNOWLEDGMENT; I INTRODUCTION TO PART I; 1 INSTRUMENTATION AND DEVELOPMENTS; 1.1 Introduction; 1.2 Ionization Techniques for Macromolecules; 1.2.1 (252)Cf Plasma Desorption Ionization; 1.2.2 Fast Atom/Ion Bombardment; 1.2.3 Type of Fragment Ions and Nomenclature; 1.3 Examples on Analytical Solutions Based on FAB-MS; 1.3.1 Detection of Abnormalities in Hemoglobin; 1.3.2 Glycoprotein Structure Determination; 1.3.3 Early Scanning Functions on Sector Machines; 1.4 Electrospray Ionization; 1.5 Matrix-Assisted Laser Desorption Ionization
1.5.1 MALDI at High Pressure1.5.2 Desorption Ionization on Silicon (DIOS); 1.5.3 Delayed Extraction; 1.6 Ion Detection; 1.6.1 Microchannel Plates (MCPs); 1.6.2 Cryogenic Detectors; 1.6.2.1 Superconducting Tunnel Junction; 1.6.2.2 Thermal Detectors; 1.7 Types of Analyzers; 1.7.1 Quadrupole Mass Filter; 1.7.2 Three-Dimensional Quadrupole Ion Trap; 1.7.3 Linear Ion Trap; 1.7.4 Time of Flight; 1.7.5 Fourier Transform Ion Cyclotron Resonance; 1.8 Hybrid Analyzers; 1.8.1 Quadrupole Time of Flight; 1.8.2 Ion Mobility-TOF; 1.8.3 Linear Ion Trap-FT-ICR; 1.8.4 Ion Trap-TOF; 1.9 Tandem Mass Spectrometry 1.9.1 Postsource Decay1.9.2 MS-MS Measurements; 1.9.3 Collisional Activation; 1.10 Current MS Instrumentation in Proteome Analyses; 1.10.1 MALDI-TOF; 1.10.2 MALDI-TOF-TOF; 1.10.3 FT-ICR-MS; 1.10.4 ION Mobility-MS; 1.11 Current MS-Based Proteomics; 1.11.1 Delivering Peptides to Ion Source; 1.11.2 Peptide Sequencing and Database Searching; 1.11.3 Peptide Mass Fingerprinting; 1.11.4 Searching with MS-MS Data; 1.11.5 Databases for MS Data Search; 1.12 Recent Achievements and Future Challenges; 1.12.1 Current Applications; 1.12.2 Signal Transduction Pathways; 1.13 Concluding Remarks; References 2 PROTEOMICS IN CANCER RESEARCH2.1 Introduction; 2.1.1 Two-Dimensional Gel Electrophoresis; 2.1.2 Surface-Enhanced Laser Desorption Ionization; 2.1.3 Protein Microarrays; 2.1.4 Getting More Than Just Simple Change in Protein Expression; 2.1.5 Laser Capture Microdissection; 2.2 Pancreatic Ductal Adenocarcinoma; 2.2.1 Analyses Based on Chip Technology; 2.2.2 SELDI Analysis of Pancreatic Ductal Adenocarcinoma; 2.2.3 Protein Profiling Following Treatment with DNA Methylation/Histone Deacetylation Inhibitors; 2.2.4 Proteomic Profiling of PDAC Following Treatment with Trichostatin A 2.2.5 Proteomic Profiling of PDAC Following Treatment with 5 ́-aza-2 ́-deoxycytidine2.3 Proteomic Analysis of Human Breast Carcinoma; 2.3.1 Two-DE Analysis in Breast Cancer; 2.3.2 Proteomic Profiling of Breast Cancer Cell Membranes; 2.3.3 Proteomic Analysis on Selected Tissue Samples; 2.4 Proteomic Profiling of Chemoresistant Cancer Cells; 2.4.1 Protein Alterations in Pancreas Carcinoma Cells Exposed to Anticancer Drug; 2.4.2 Proteomic Profiling of Cervix Squamous Cell Carcinoma Treated with Cisplatin; 2.5 Signal Pathway Profiling of Prostate Cancer 2.6 Emerging Role of Functional and Activity-Based Proteomics in Disease Understanding |
Record Nr. | UNINA-9910144639903321 |
Hamdan Mahmoud <1947-> | ||
Hoboken, N.J., : John Wiley & Sons, 2005 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Proteomics today [[electronic resource] ] : protein assessment and biomarkers using mass spectrometry, 2D electrophoresis, and microarray technology / / Mahmoud Hamdan, Pier Giorgio Righetti |
Autore | Hamdan Mahmoud <1947-> |
Pubbl/distr/stampa | Hoboken, N.J., : John Wiley & Sons, 2005 |
Descrizione fisica | 1 online resource (446 p.) |
Disciplina |
572.6
572.636 |
Altri autori (Persone) | RighettiP. G |
Collana | Wiley-Interscience series in mass spectrometry |
Soggetto topico |
Proteins - Spectra
Mass spectrometry Proteomics |
ISBN |
1-280-27548-0
9786610275489 0-470-24684-7 0-471-70910-7 0-471-70915-8 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
PROTEOMICS TODAY; CONTENTS; PREFACE TO PART I; ACKNOWLEDGMENT; I INTRODUCTION TO PART I; 1 INSTRUMENTATION AND DEVELOPMENTS; 1.1 Introduction; 1.2 Ionization Techniques for Macromolecules; 1.2.1 (252)Cf Plasma Desorption Ionization; 1.2.2 Fast Atom/Ion Bombardment; 1.2.3 Type of Fragment Ions and Nomenclature; 1.3 Examples on Analytical Solutions Based on FAB-MS; 1.3.1 Detection of Abnormalities in Hemoglobin; 1.3.2 Glycoprotein Structure Determination; 1.3.3 Early Scanning Functions on Sector Machines; 1.4 Electrospray Ionization; 1.5 Matrix-Assisted Laser Desorption Ionization
1.5.1 MALDI at High Pressure1.5.2 Desorption Ionization on Silicon (DIOS); 1.5.3 Delayed Extraction; 1.6 Ion Detection; 1.6.1 Microchannel Plates (MCPs); 1.6.2 Cryogenic Detectors; 1.6.2.1 Superconducting Tunnel Junction; 1.6.2.2 Thermal Detectors; 1.7 Types of Analyzers; 1.7.1 Quadrupole Mass Filter; 1.7.2 Three-Dimensional Quadrupole Ion Trap; 1.7.3 Linear Ion Trap; 1.7.4 Time of Flight; 1.7.5 Fourier Transform Ion Cyclotron Resonance; 1.8 Hybrid Analyzers; 1.8.1 Quadrupole Time of Flight; 1.8.2 Ion Mobility-TOF; 1.8.3 Linear Ion Trap-FT-ICR; 1.8.4 Ion Trap-TOF; 1.9 Tandem Mass Spectrometry 1.9.1 Postsource Decay1.9.2 MS-MS Measurements; 1.9.3 Collisional Activation; 1.10 Current MS Instrumentation in Proteome Analyses; 1.10.1 MALDI-TOF; 1.10.2 MALDI-TOF-TOF; 1.10.3 FT-ICR-MS; 1.10.4 ION Mobility-MS; 1.11 Current MS-Based Proteomics; 1.11.1 Delivering Peptides to Ion Source; 1.11.2 Peptide Sequencing and Database Searching; 1.11.3 Peptide Mass Fingerprinting; 1.11.4 Searching with MS-MS Data; 1.11.5 Databases for MS Data Search; 1.12 Recent Achievements and Future Challenges; 1.12.1 Current Applications; 1.12.2 Signal Transduction Pathways; 1.13 Concluding Remarks; References 2 PROTEOMICS IN CANCER RESEARCH2.1 Introduction; 2.1.1 Two-Dimensional Gel Electrophoresis; 2.1.2 Surface-Enhanced Laser Desorption Ionization; 2.1.3 Protein Microarrays; 2.1.4 Getting More Than Just Simple Change in Protein Expression; 2.1.5 Laser Capture Microdissection; 2.2 Pancreatic Ductal Adenocarcinoma; 2.2.1 Analyses Based on Chip Technology; 2.2.2 SELDI Analysis of Pancreatic Ductal Adenocarcinoma; 2.2.3 Protein Profiling Following Treatment with DNA Methylation/Histone Deacetylation Inhibitors; 2.2.4 Proteomic Profiling of PDAC Following Treatment with Trichostatin A 2.2.5 Proteomic Profiling of PDAC Following Treatment with 5 ́-aza-2 ́-deoxycytidine2.3 Proteomic Analysis of Human Breast Carcinoma; 2.3.1 Two-DE Analysis in Breast Cancer; 2.3.2 Proteomic Profiling of Breast Cancer Cell Membranes; 2.3.3 Proteomic Analysis on Selected Tissue Samples; 2.4 Proteomic Profiling of Chemoresistant Cancer Cells; 2.4.1 Protein Alterations in Pancreas Carcinoma Cells Exposed to Anticancer Drug; 2.4.2 Proteomic Profiling of Cervix Squamous Cell Carcinoma Treated with Cisplatin; 2.5 Signal Pathway Profiling of Prostate Cancer 2.6 Emerging Role of Functional and Activity-Based Proteomics in Disease Understanding |
Record Nr. | UNINA-9910831066403321 |
Hamdan Mahmoud <1947-> | ||
Hoboken, N.J., : John Wiley & Sons, 2005 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Proteomics today : protein assessment and biomarkers using mass spectrometry, 2D electrophoresis, and microarray technology / / Mahmoud Hamdan, Pier Giorgio Righetti |
Autore | Hamdan Mahmoud <1947-> |
Pubbl/distr/stampa | Hoboken, N.J., : John Wiley & Sons, 2005 |
Descrizione fisica | 1 online resource (446 p.) |
Disciplina | 572/.6 |
Altri autori (Persone) | RighettiP. G |
Collana | Wiley-Interscience series in mass spectrometry |
Soggetto topico |
Proteins - Spectra
Mass spectrometry Proteomics |
ISBN |
1-280-27548-0
9786610275489 0-470-24684-7 0-471-70910-7 0-471-70915-8 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
PROTEOMICS TODAY; CONTENTS; PREFACE TO PART I; ACKNOWLEDGMENT; I INTRODUCTION TO PART I; 1 INSTRUMENTATION AND DEVELOPMENTS; 1.1 Introduction; 1.2 Ionization Techniques for Macromolecules; 1.2.1 (252)Cf Plasma Desorption Ionization; 1.2.2 Fast Atom/Ion Bombardment; 1.2.3 Type of Fragment Ions and Nomenclature; 1.3 Examples on Analytical Solutions Based on FAB-MS; 1.3.1 Detection of Abnormalities in Hemoglobin; 1.3.2 Glycoprotein Structure Determination; 1.3.3 Early Scanning Functions on Sector Machines; 1.4 Electrospray Ionization; 1.5 Matrix-Assisted Laser Desorption Ionization
1.5.1 MALDI at High Pressure1.5.2 Desorption Ionization on Silicon (DIOS); 1.5.3 Delayed Extraction; 1.6 Ion Detection; 1.6.1 Microchannel Plates (MCPs); 1.6.2 Cryogenic Detectors; 1.6.2.1 Superconducting Tunnel Junction; 1.6.2.2 Thermal Detectors; 1.7 Types of Analyzers; 1.7.1 Quadrupole Mass Filter; 1.7.2 Three-Dimensional Quadrupole Ion Trap; 1.7.3 Linear Ion Trap; 1.7.4 Time of Flight; 1.7.5 Fourier Transform Ion Cyclotron Resonance; 1.8 Hybrid Analyzers; 1.8.1 Quadrupole Time of Flight; 1.8.2 Ion Mobility-TOF; 1.8.3 Linear Ion Trap-FT-ICR; 1.8.4 Ion Trap-TOF; 1.9 Tandem Mass Spectrometry 1.9.1 Postsource Decay1.9.2 MS-MS Measurements; 1.9.3 Collisional Activation; 1.10 Current MS Instrumentation in Proteome Analyses; 1.10.1 MALDI-TOF; 1.10.2 MALDI-TOF-TOF; 1.10.3 FT-ICR-MS; 1.10.4 ION Mobility-MS; 1.11 Current MS-Based Proteomics; 1.11.1 Delivering Peptides to Ion Source; 1.11.2 Peptide Sequencing and Database Searching; 1.11.3 Peptide Mass Fingerprinting; 1.11.4 Searching with MS-MS Data; 1.11.5 Databases for MS Data Search; 1.12 Recent Achievements and Future Challenges; 1.12.1 Current Applications; 1.12.2 Signal Transduction Pathways; 1.13 Concluding Remarks; References 2 PROTEOMICS IN CANCER RESEARCH2.1 Introduction; 2.1.1 Two-Dimensional Gel Electrophoresis; 2.1.2 Surface-Enhanced Laser Desorption Ionization; 2.1.3 Protein Microarrays; 2.1.4 Getting More Than Just Simple Change in Protein Expression; 2.1.5 Laser Capture Microdissection; 2.2 Pancreatic Ductal Adenocarcinoma; 2.2.1 Analyses Based on Chip Technology; 2.2.2 SELDI Analysis of Pancreatic Ductal Adenocarcinoma; 2.2.3 Protein Profiling Following Treatment with DNA Methylation/Histone Deacetylation Inhibitors; 2.2.4 Proteomic Profiling of PDAC Following Treatment with Trichostatin A 2.2.5 Proteomic Profiling of PDAC Following Treatment with 5 ́-aza-2 ́-deoxycytidine2.3 Proteomic Analysis of Human Breast Carcinoma; 2.3.1 Two-DE Analysis in Breast Cancer; 2.3.2 Proteomic Profiling of Breast Cancer Cell Membranes; 2.3.3 Proteomic Analysis on Selected Tissue Samples; 2.4 Proteomic Profiling of Chemoresistant Cancer Cells; 2.4.1 Protein Alterations in Pancreas Carcinoma Cells Exposed to Anticancer Drug; 2.4.2 Proteomic Profiling of Cervix Squamous Cell Carcinoma Treated with Cisplatin; 2.5 Signal Pathway Profiling of Prostate Cancer 2.6 Emerging Role of Functional and Activity-Based Proteomics in Disease Understanding |
Record Nr. | UNINA-9910877867003321 |
Hamdan Mahmoud <1947-> | ||
Hoboken, N.J., : John Wiley & Sons, 2005 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|